Aberrant PI3K/AKT signalling has been described in many human cancers, including soft tissue sarcomas [51,52,53,54,55,56,57], and AKT activation contributes to pathways that promote tumour cell proliferation, invasion and metastasis [58,59]. This evidence concerns the gene AKT1 and cancer.